Mural Oncology PLC

Biotechnology • Healthcare • Dublin, Ireland • MURA (NGM)

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland. As of December 4, 2025, Mural Oncology plc operates as a subsidiary of XOMA Royalty Corporation.

353 1 905 8020 10 Earlsfort Terrace, Ireland

Stock Performance (90 Days)

Data through Dec 9, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan

Stock Titan • Dec 5

Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative

Quiver Quantitative • Dec 5

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - Yahoo Finance

Yahoo Finance • Dec 5

Mural Oncology Plc Completes Acquisition by XRA 5 Corp. - TipRanks

TipRanks • Dec 5

MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders - Business Wire

Business Wire • Aug 20

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Mural Oncology plc had layoffs?

No layoff events have been recorded for Mural Oncology plc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Mural Oncology plc have?

Mural Oncology plc has approximately 116 employees.

What industry is Mural Oncology plc in?

Mural Oncology plc operates in the Biotechnology industry, within the Healthcare sector.

Is Mural Oncology plc a publicly traded company?

Yes, Mural Oncology plc is publicly traded under the ticker symbol MURA on the NGM. The company has a market capitalization of approximately $0.04 billion.

Where is Mural Oncology plc headquartered?

Mural Oncology plc is headquartered in Dublin, Ireland at 10 Earlsfort Terrace, Ireland.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.